U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07819292) titled 'HEART-BC: Heart Transplant Evaluation Using Advanced Rejection Monitoring Tools - British Columbia' on Sept. 08.
Brief Summary: Evaluate whether integration of HeartCare (AlloMap + AlloSure) into routine post-transplant surveillance reduces the number of invasive endomyocardial biopsies (EMBx) in the first year post-transplant
Study Start Date: Jan. 01, 2027
Study Type: OBSERVATIONAL
Condition:
Heart Transplant Recipient
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Cardiology Research UBC
Information provided by (Responsible Party): Nima Moghaddam, Cardiology Research UBC
Published by HT Digital Content Services with per...